Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001104659-25-106048·Evoke Pharma Inc
Schedule 13D ownership disclosure
EVOKE PHARMA INC
Common Stock, par value $0.0001 per share · CUSIP: 30049G302
Event date: 2025-11-03
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Nantahala Capital Management, LLCReported CIK 0001472322
Shares: 268,431.00 · Class: 15.99%
- Harkey Wilmot B.Reported CIK 0001775952
Shares: 268,431.00 · Class: 15.99%
- Mack DanielReported CIK 0001775831
Shares: 268,431.00 · Class: 15.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-106048
- Form type
- SCHEDULE 13D/A
- Filer
- Evoke Pharma Inc
- CIK
- CIK 1403708
- Filed
- Nov 04, 2025
- Reporting period
- Nov 03, 2025
- Description
- Schedule 13D beneficial ownership